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Calculations Skills: Inducing Remission in Crohn’s Disease 
Affecting approximately 115,000 people in the UK (Crohn’s & Colitis UK, 2013), Crohn’s 
disease is a chronic inflammatory disease of the gastrointestinal (GI) tract, presenting with 
periods of remission and relapse (NICE, 2015). The inflammation is intermittent, with sections 
of unaffected GI tract between the inflamed sections. Symptoms of Crohn’s disease vary 
between individuals but include loss of appetite, mouth ulceration, weight loss, diarrhoea, 
fatigue, abdominal pain and  anaemia (Crohn’s & Colitis UK, 2013). As well as the associated 
psychological impact of Crohn’s disease, it can also result in a range of physical complications 
including malnutrition, intestinal strictures, abcesses, fistulas and cancers (NICE, 2015). 
Question 1 
(i) What is the ratio of people in the UK (with a population of 65.1 million) with Crohn’s 
disease to those without? 
(ii) Manchester has a population of 527,239. Based on the ratio identified in the 
previous answer, identify how people in Manchester are likely to have Crohn’s 
disease?  
Question 2 
Rachel, a 38 year old nurse, has been diagnosed with Crohn’s disease. In line with NICE 
(2016) guidance, she is to be prescribed monotherapy of a glucocorticosteroid with the aim of 
inducing remission. Both prednisilone and methylprednisilone are deemed appropriate, 
although budesonide could be given in the event of intolerance to prednisilone and 
methylprednisolone. 
(i) What would be the cost of a 2 week treatment of budesonide (calculated on price per 
capsule)? Round the final cost up or down to the nearest pence. 
(ii) What combination of methylprednisilone tablets would be required to provide the 
maximum daily dose with the fewest tablets? 
(iii) What would be the cost of the mid-range dose of prednisolone (using the fewest 
tablets) for 7 days treatment (calculated on price per tablet rounded up or down to the 
nearest pence)? 
 
Table 1: Monotherapy to induce remission 
Drug Dose Cost 
Prednisilone 20-40mg daily 10mg tablets £2.72 28 tablets 
20mg tablets £5.43 28 tablets 
30mg tablets £8.15 28 tablets 
 
Methylprednisilone 2-40mg daily 2mg tablets £3.88 30 tablets 
4mg tablets £6.19 30 tablets 
16mg tablets £17.17 30 tablets 
 
Budesonide 9mg 3mg capsules £75.05 100 capsules 
 
 
 
Question 3 
Ben, a 28 year old mechanic, weighing 70kg, is experiencing his second exacerbation of 
Crohn’s disease in 8 months. In line with NICE (2016) guidance, he is to be prescribed an 
add-on treatment to a glucocorticosteroid. Azathioprine and mercaptopurine are suitable add-
on treatments and the recommended dose is identified in table 2. 
(i) What would be the maximum daily dose of azathioprine for Ben? 
(ii) Based on the minimum daily dose of mercaptopurine for Ben, how much of the 
drug (in grams) would he have taken in a 3 week period? 
Table 2: Add-on treatment 
Add-on treatment Dose 
azathioprine 2-2.5mg/kg daily 
mercaptopurine 1-1.5mg/kg daily 
 
Question 4 
Suzie, a 25 year old teacher, has recently been receiving monotherapy for her third relapse in 
12 months but this has not achieved remission. Treatment of previous relapses identified an 
intolerance to azathioprine and mercaptopurine, so she is to be prescribed methotrexate as 
an add-on treatment. The dose of methotrexate required is 25mg once weekly until remission 
is induced followed by a maintenance dose of 15mg once weekly. 
(i) If Suzie receives 25mg of methotrexate for 3 weeks, followed by 5 weeks on the 
maintenance dose, how much methotrexate would she have taken over the eight 
week period? 
(ii) What is the mean weekly dose over this period? 
Question 5 
Despite conventional therapy of monotherapy followed by a period of treatment with an add-
on drug, Jacob has had little response and is therefore to commence on adalimumab as a 
monotherapy in order to induce remission. This is to be administered by sub-cutaneous 
injection. Table 3 identifies the recommended regime. 
Table 3: Adalimumab 
Week Dose 
1 80mg 
3 40mg 
Week 5 onwards, maintenance dose 2 weekly (increased if 
necessary to once weekly) 
40mg 
(i) Assuming the regime in table 3 is followed and the maintenance dose remains at 
2 weekly intervals, how much adalimumab will Jacob have received over a 10 week 
period? 
(ii) If the maintenance dose had been changed to weekly from week 7 onwards, how 
much adalimumab will Jacob have received over a 10 week period? 
 
 
Answers 
Question 1 
(i) 65,100,000 ÷115,000 = 566 
Ratio = 1:566 
(ii)527,239 ÷ 566 = 932 (rounded up) 
 
Question 2 
(i) 100 capsules = £75.05 
1 capsule = 7505 ÷ 100 = 75.05p 
Required number of tablets = 3 x 14 = 42 
42 x 75.05p = £31.52 
 
(ii) Required dose = 40mg 
(16mg x 2) + (4mg x 2) = 40mg 
 
(iii) Mid-range dose = 30mg 
28 tablets = £8.15 
1 tablet = £8.15 ÷ 28 = 29p (rounded down) 
7 x 29p = £2.04 
 
Question 3 
(i) 2.5mg x 70 (kg) = 175mg daily 
(ii) 1mg x 70 (kg) x 21 (days) = 1470mg / 1.47g 
 
Question 4 
(i) (25mg x 3) + (15mg x 5) = 75mg + 75mg = 150mg 
 
(ii) Mean = sum of all doses divided by number of doses 
 
150mg ÷ 8 = 18.75mg 
 
 
Question 5 
(i) 80 + 40 + 40 + 40 + 40 = 240mg 
(ii) 80 + 40 + 40 + 40 + 40 + 40 + 40 = 320mg 
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